ELAPRASE
ELAPRASE
Approved
DIN Number
02296314
Drug Class
Human
Market Date
Aug 1, 2007
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02296314
AIG Number0152221001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB09 IDURSULFASE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IDURSULFASEActive
Strength: 2 MG / ML
Monograph: IDURSULFASE